Navigation Links
EFT BioTech Holdings, Inc.'s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait
Date:6/30/2009

- The 2,292-ton Ocean Lala sailed from the Taichung Harbor to Xiamen, China and carried 179 passengers and 23 crew members -

CITY OF INDUSTRY, Calif. and HONG KONG, June 30 /PRNewswire-FirstCall/ -- EFT BioTech Holdings, Inc. (Pink Sheets: EFTB) announced today that the Company's subsidiary, Excalibur International Marine Corporation, completed its inaugural passenger voyage across the Taiwan Strait on June 28, 2009. The voyage across the Taiwan Strait takes only 4 1/2 hours, but it took Taiwan and China 60 years to ease tension and for Taipei to agree to lift the ban on sea links with China's mainland.

The voyage was featured in a news article that has run in several internet news sites, including the Taiwan Sun and the Qatar Tribune. Jack Qin, the President and CEO of EFT BioTech Holdings, Inc., stated, "We are excited to be recognized by the regional press and this coverage shows that people are truly interested in this much needed passenger and cargo service."

In October 2008, EFT, through a wholly-owned subsidiary, EFT Investment Company Ltd. purchased a 49% interest in Excalibur International Marine Corporation.

About EFT BioTech Holdings, Inc.

EFT BioTech Holdings, Inc. is a Nevada holding company which conducts its business through its wholly-owned subsidiary, EFT Biotech, Inc., and its wholly owned subsidiaries and various vested interests. EFT BioTech Holdings, Inc. is a B2B e-commerce company serving consumers with EFT's "made in USA" neutraceuticals, health and beauty EFT branded products through its proprietary online business platform and website, www.eftb.us. Although our products are available for sale throughout the world, most Affiliates and consumers are located in China and Hong Kong. The contents of the Company's website are not incorporated by reference herein. Th
'/>"/>

SOURCE EFT BioTech Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
3. The MedZilla Report: May 2009 Employment Outlook for Biotech/Pharma/Health
4. Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock
5. Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference
6. Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
7. Nanobiotech Center Wins $2.5 Million, 4-Year Grant
8. A-WIT Technologies Releases World's First Low Cost C Stamp(TM) Based Biotechnology Laboratory in a Box
9. Yongye Biotechnology International Receives License to Manufacture Products
10. American Biotech Labs(R) Garners 2009 Utah Best of State Award
11. Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ries have an opportunity to take the lead in two s...niversity of Valencia (UV), working together with ...e fabric of the Spanish biotechnology industry. Th...ors have more clout than those in English-speaking...nd plants has been overlooked by the leading count...
(Date:11/20/2009)... Cell Therapeutics, Inc. ...the Ninth Circuit Court of Appeals reversed a U.S.... allowed to pursue all of its claims against The L...ourt for trial. CTI filed a complaint against The...t consultant for CTI,s product TRISENOX, in 2007 s...
(Date:11/19/2009)...ewswire-FirstCall/ -- Omeros Corporation (Nasdaq: ...s for the third quarter ended September 30, 2009. ...ros reported a net loss of $3.9 million, or $1.34 ...on, or $2.54 per share, for the same period in 200...he Company reported a net loss of $15.5 million, o...
(Date:11/19/2009)...WALTHAM, Mass., Nov. 19 Arlington ...d that the leading driver of antibiotic selection ...m activity against gram-positive and gram-negative...an cause nosocomial pneumonia, surveyed European p...ts that provide appropriate coverage against commo...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
... ) today,announced that its Board of Directors has...enior Vice President, Corporate Affairs effective,..., who has announced her,plans to retire., Prior t...dent,Corporate Affairs at ARAMARK since 2003. Duri...cutive roles for several leading companies. He for...
...gies,Inc. (Amex: PTN ) will announce its second q... period ended December 31, 2007 on February 11,200... The Company will also conduct a teleconference an... management team on February 11, 2008 at which,the...r detail and provide,an update on corporate develo...
...ation,(Nasdaq: DRRX ) announced today financial r...r 31, 2007. Total revenues were $6.6 million for t...to $5.4 million for the same,period in 2006. Net l...as,$7.2 million, compared to a net loss of $9.8 mi...//www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )...
Other Biology Technology:Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs 2Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th 2DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 2DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 3DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 4DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 5DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 6DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 7DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 8DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 9
(Date:11/19/2009)...ing the genetic instructions inside corn, one of t... of the most complex sequences of DNA ever analyze... David Schwartz, who was one of more than 100 auth...The maize genome is a true maze full of confusing... sequencers for years," says Schwartz. , Publica...
(Date:11/19/2009)...in maize, also known as corn, researchers across t...hould pave the way to significant improvements in ...al feed and fiber around the world. , The new ma... map, charts genetic diversity and recombination a...research team, led by U.S. Department of Agricultu...
(Date:11/19/2009)... T. Ming Chu Professor of Biochemistry and Molecul...ng how regulatory proteins control the production ...rking with collaborators including Drs. Mitchell W...ladelphia, they focused specifically on the comple...es). These cells contain large amounts of hemoglob...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 1Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 3Mice run faster on high grade oil 9038 1Mice run faster on high grade oil 9038 2Super sleepers could help super sizers 21 9034 1Super sleepers could help super sizers 21 9034 2
...ons to Identify Individuals for Access to ...s, WALL, N.J., Sept. 22 BIO-key International,In...based biometric,identification and wireless public...ork, is showcasing its fingerprint biometric solut...ing held at the Moscone Center in San,Francisco fr...
... 22, 2008) Researchers at the University of Calga... infections in people with cystic fibrosis (CF). T... National Academy of Science USA, this week. , ...e with CF. Pseudomonas aeruginosa is a common bact...ciated with severe lung infections. Pseudomonas re...
...entists and news organizations typically focus on ...s, but research at the University of Michigan sugg...n large numbers of people are the key to understan...ctious disease: cholera. , Using a model develope...d their collaborators came up with results that ch...
Other Biology News:BIO-key(R) International To Exhibit at Oracle OpenWorld 2BIO-key(R) International To Exhibit at Oracle OpenWorld 3BIO-key(R) International To Exhibit at Oracle OpenWorld 4New approach to treating cystic fibrosis lung infection shows promise 2Hidden infections crucial to understanding, controlling disease outbreaks 2Hidden infections crucial to understanding, controlling disease outbreaks 3
Human HGF, Unconjugated from R&D Systems
Anti-alpha1-Antitrypsin Monoclonal Antibody, Unconjugated from CHEMICON
Senescence Colorimetric Assay Kit from BioVision
Mouse LIGHT / TNFSF14, Unconjugated from R&D Systems
Biology Products: